Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Speaker: Roberto Mina, MD – European Myeloma Network, Italy

Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Panelist: Roberto Mina, MD – European Myeloma Network, Italy

Panelist: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Panelist: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Panelist: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Co-Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Adam D. Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Panelist: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Panelist: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Panelist: Adam D. Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Panelist: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Chair: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Speaker: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Speaker: Susan Bal, MD – University of Alabama at Birmingham

Speaker: Cesar Rodriguez, MD – Icahn School of Medicine at Mount Sinai

Speaker: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Speaker: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Chair: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Elias K. Mai (he/him/his) – Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Chair: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Speaker: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Speaker: Donna E. Reece, MD (she/her/hers) – University Health Network, Princess Margaret Cancer Centre

Speaker: Craig Emmitt Cole, MD (he/him/his) – Karmanos Cancer Institute-Wayne State and Michigan State University

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Panelist: Donna E. Reece, MD (she/her/hers) – University Health Network, Princess Margaret Cancer Centre

Panelist: Craig Emmitt Cole, MD (he/him/his) – Karmanos Cancer Institute-Wayne State and Michigan State University

Panelist: Cyrille Touzeau, MD, PhD – CHU Nantes